The Managing Director/CEO of Neimeth International Pharmaceuticals Plc, Dr. Ebere Ekpunobi, has won the GSK Inventor Award for two patent applications covering her inventions during her tenure at GSK. Ekpunobi’s invention is related to the discovery of compounds potentially useful for the treatment of a rare disease. The award was instituted by GSK Research & Development Centre in Shanghai, China to adequately recognise the contributions made into taking a molecule through the length of the drug development pipeline to the launch of a valuable medicine.

In a letter conveying the award, Senior Counsel, Global Patents at GSK, Fang Qian, stated the inventor award recognises “the importance of intellectual property, and the contribution of inventors to the patents that are critical to creating value for patients and for the company.

Ekpunobi a graduate of Pharmacy from the University of Nigeria Nsukka, holds Ph.D in Pharmacy Administration from Purdue University, W. Lafayette Indiana USA.

She started her career as a Community Pharmacist in Nigeria, moved to the United States and joined Burroughs Welcome as Product Manager for Retrovir in 1992, rising to the position of Director, Commercial Strategy, HIV/Anti-infectives in 1999 in Glaxo Welcome. By 2010 she had been appointed Head, Research & Development Commercial Insights, CVM/NS Global Franchise, in Shanghai China, from where she joined Neimeth International Pharmaceuticals Plc.